IO Biotech, Inc.
Cash Flow Statement
| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-8.4M | $-26.2M | $-22.4M | $-24.0M | $-20.7M | $-19.5M | $-21.7M | $-21.2M |
| Depreciation & Amortization | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K |
| Depreciation | — | — | $61.0K | — | — | $62.0K | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | $1.6M | — | — | $1.6M | — | — |
| Net Cash from Operating Activities | $-18.5M | $-19.8M | $-23.1M | $-20.8M | $-17.0M | $-24.9M | $-16.0M | $-18.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $4.0K | $26.0K | $28.0K | $10.0K | $12.0K | $11.0K | $24.0K | $39.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $-28.0K | — | — | $-11.0K | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | $0 | — | — | $0 | — | — |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-18.5M | $-19.8M | $-23.1M | $-20.8M | $-17.0M | $-24.9M | $-16.0M | $-18.3M |